Theres practically no chance that any single ingredient is present in a high enough dose to affect your lifespan
We have a full summary of all the major pre-clinical studies and trials below, but as Reta is in Phase III, it's clear that: It showed significant benefit and low safety risk during pre-clinical trials to justify clinical trials
Allulose, also known as D-psicose, is a low-calorie monosaccharide sugar that is naturally present in small quantities in certain foods, including wheat, figs, and raisins
Research-Grade BPC-157 vs Compounded BPC-157 There are two distinct supply channels for BPC-157, and the 2026 FDA activity only affects one of them: Research/laboratory grade: Sold by peptide research suppliers with third-party certificates of analysis (COA)
and A.S., are cofounders of NADMED Ltd
Is this normal, or is something wrong